These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 11159158)
1. Impact of estrogen use on decline in cognitive function in a representative sample of older community-resident women. Fillenbaum GG; Hanlon JT; Landerman LR; Schmader KE Am J Epidemiol; 2001 Jan; 153(2):137-44. PubMed ID: 11159158 [TBL] [Abstract][Full Text] [Related]
2. The relationship of APOE genotype to cognitive functioning in older African-American and Caucasian community residents. Fillenbaum GG; Landerman LR; Blazer DG; Saunders AM; Harris TB; Launer LJ J Am Geriatr Soc; 2001 Sep; 49(9):1148-55. PubMed ID: 11559372 [TBL] [Abstract][Full Text] [Related]
3. Is antioxidant use protective of cognitive function in the community-dwelling elderly? Gray SL; Hanlon JT; Landerman LR; Artz M; Schmader KE; Fillenbaum GG Am J Geriatr Pharmacother; 2003 Sep; 1(1):3-10. PubMed ID: 15555461 [TBL] [Abstract][Full Text] [Related]
5. Protective effect of chronic NSAID use on cognitive decline in older persons. Rozzini R; Ferrucci L; Losonczy K; Havlik RJ; Guralnik JM J Am Geriatr Soc; 1996 Sep; 44(9):1025-9. PubMed ID: 8790225 [TBL] [Abstract][Full Text] [Related]
6. Equivalence of two screens of cognitive functioning: the Short Portable Mental Status Questionnaire and the Orientation-Memory-Concentration test. Fillenbaum GG; Landerman LR; Simonsick EM J Am Geriatr Soc; 1998 Dec; 46(12):1512-8. PubMed ID: 9848811 [TBL] [Abstract][Full Text] [Related]
7. Relationship of race/ethnicity and blood pressure to change in cognitive function. Bohannon AD; Fillenbaum GG; Pieper CF; Hanlon JT; Blazer DG J Am Geriatr Soc; 2002 Mar; 50(3):424-9. PubMed ID: 11943035 [TBL] [Abstract][Full Text] [Related]
8. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D; JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113 [TBL] [Abstract][Full Text] [Related]
9. Histamine2 receptor antagonist use and decline in cognitive function among community dwelling elderly. Hanlon JT; Landerman LR; Artz MB; Gray SL; Fillenbaum GG; Schmader KE Pharmacoepidemiol Drug Saf; 2004 Nov; 13(11):781-7. PubMed ID: 15386717 [TBL] [Abstract][Full Text] [Related]
10. Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging. Baldereschi M; Di Carlo A; Lepore V; Bracco L; Maggi S; Grigoletto F; Scarlato G; Amaducci L Neurology; 1998 Apr; 50(4):996-1002. PubMed ID: 9566385 [TBL] [Abstract][Full Text] [Related]
11. A prospective study of physical activity and cognitive decline in elderly women: women who walk. Yaffe K; Barnes D; Nevitt M; Lui LY; Covinsky K Arch Intern Med; 2001 Jul; 161(14):1703-8. PubMed ID: 11485502 [TBL] [Abstract][Full Text] [Related]
12. Impact of anemia on mortality, cognition, and function in community-dwelling elderly. Denny SD; Kuchibhatla MN; Cohen HJ Am J Med; 2006 Apr; 119(4):327-34. PubMed ID: 16564775 [TBL] [Abstract][Full Text] [Related]
13. Cross-linked fibrin degradation products (D-dimer), plasma cytokines, and cognitive decline in community-dwelling elderly persons. Wilson CJ; Cohen HJ; Pieper CF J Am Geriatr Soc; 2003 Oct; 51(10):1374-81. PubMed ID: 14511156 [TBL] [Abstract][Full Text] [Related]
14. Memory complaint as a predictor of cognitive decline: a comparison of African American and White elders. Blazer DG; Hays JC; Fillenbaum GG; Gold DT J Aging Health; 1997 May; 9(2):171-84. PubMed ID: 10182402 [TBL] [Abstract][Full Text] [Related]
15. Do older women use estrogen replacement? Data from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE). Handa VL; Landerman R; Hanlon JT; Harris T; Cohen HJ J Am Geriatr Soc; 1996 Jan; 44(1):1-6. PubMed ID: 8537578 [TBL] [Abstract][Full Text] [Related]
16. Postmenopausal hormone therapy and its association with cognitive impairment. Mitchell JL; Cruickshanks KJ; Klein BE; Palta M; Nondahl DM Arch Intern Med; 2003 Nov; 163(20):2485-90. PubMed ID: 14609785 [TBL] [Abstract][Full Text] [Related]